Clinical Trial Update: Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Enarodustat plus cyclosporine versus cyclosporine alone for newly diagnosed transfusion-dependent non-severe aplastic anemia. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Enarodustat (enarodustat)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Transfusion-dependent Non-severe Aplastic Anemia | Phase 3 | Status: NOT_YET_RECRUITING